IL1B and acute respiratory distress syndrome: Dehydrodieugenol B (20-60 mg/kg/weight) prevented pulmonary remodeling in an animal model of ALI by reducing inflammatory cells, lung edema, IL-6 and IL-1β levels, iNOS, and collagen content and expression.